GenoScreen
PrivateLast Round
Early Funding
Dec 1, 2021
Total Funding Raised
$2.27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GenoScreen is a biotechnology company that provides genomic information services, including DNA sequencing, genotyping, and bioinformatics analysis for research and industrial applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenoScreen Comparables
Compare GenoScreen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| bioMérieux | 82% | |
| AbL Diagnostics SA | 79% | |
| Biotia | 77% |
GenoScreen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Dec 1, 2021 | ||||
| Early Funding | Jan 28, 2019 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 37% MoM.
- Jul 6, 2025
Monthly visitors grew 41% MoM, reaching 2.4K.
GenoScreen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GenoScreen's valuation, stock price, and market status.
Is GenoScreen a public or private company?
GenoScreen is a private company.
What is the current stock price of GenoScreen?
GenoScreen is a private company with no public stock price. No recent secondary market data is available.
How much is GenoScreen worth (valuation)?
Valuation information for GenoScreen is not publicly available.
Can I buy GenoScreen stock?
GenoScreen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GenoScreen's last funding round?
GenoScreen's most recent funding round was Early Funding on December 1, 2021.
Who are the main investors in GenoScreen?
Investor information for GenoScreen is not publicly disclosed.
Will GenoScreen IPO soon?
No public IPO plans have been announced for GenoScreen.
How can I track GenoScreen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GenoScreen's secondary market activity and sign up for updates.